☆ 4.7 Article

GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response

BRAIN (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia

D. Pellerin et al.

Summary: A repeat expansion in the FGF14 gene was found to be associated with late-onset cerebellar ataxias (LOCAs) in French Canadian and German populations as well as in Australian and Indian patients. This discovery provides important insights for further research and diagnosis of LOCAs.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Genetics & Heredity

An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50/ATX-FGF14

Haloom Rafehi et al.

Summary: This study identified an intronic (GAA) repeat expansion in FGF14 and demonstrated that (GAA)>335 is a disease-causing variant while (GAA)>250 is likely pathogenic. Affected individuals presented with adult-onset cerebellar ataxia with variable features.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

添加到收藏夹

Review Clinical Neurology

N-of-1 Trials in Neurology A Systematic Review

Bas C. Stunnenberg et al.

Summary: This study conducted a systematic review of published N-of-1 trials in neurologic disorders, focusing on methodological quality and reporting. Most trials were in neuromuscular and neurodegenerative/movement disorders, with applications in stable chronic conditions and progressive or acute disorders. N-of-1 trials show potential for bridging the gap between research and clinical care by providing a personalized evidence base for suitable treatments.

NEUROLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives

Matthis Synofzik et al.

Summary: ASO therapies offer a promising disease-modifying approach for rare neurological diseases, but there is a need to focus on ultrarare or private variants to provide treatment for a larger share of patients. The emerging field of n-of-1 ASO treatment approaches requires systematic guidance and standards to allow global scaling, particularly in the European context. Genetic, regulatory, and ethical perspectives are essential for preparing and implementing n-of-1 ASO treatments to ensure both individual patient benefit and knowledge gain.

NUCLEIC ACID THERAPEUTICS (2022)

添加到收藏夹

Article Clinical Neurology

Blood Neurofilament Light Chain in Genetic Ataxia: A Meta-Analysis

Linliu Peng et al.

Summary: The study confirms the potential of NfL as a biomarker in genetic ataxia, predicting disease onset, severity, and progression. Reference-range setting of bNfL should be divided according to age.

MOVEMENT DISORDERS (2022)

添加到收藏夹

Editorial Material Clinical Neurology

Paving the Way Toward Meaningful Trials in Ataxias: An Ataxia Global Initiative Perspective

Thomas Klockgether et al.

MOVEMENT DISORDERS (2022)

添加到收藏夹

Article Clinical Neurology

Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type

Carlo Wilke et al.

Summary: The study investigates the potential use of neurofilament light (NfL) as a biomarker in repeat-expansion spinocerebellar ataxias (SCAs). The findings suggest that NfL levels are increased not only in the ataxic stage of SCA1 but also in its preataxic stage. The study highlights the potential of using NfL as a sensitive marker for early neurodegeneration in SCA1.

NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study

T. Bogdan et al.

Summary: This study comprehensively described the etiology of sporadic late-onset cerebellar ataxia (SLOCA) and provided clues for the diagnostic workup. They identified 26 different causes for SLOCA, with multiple system atrophy cerebellar type being the most frequent. They also discovered 11 genetic causes for SLOCA.

JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease

Andreas Traschutz et al.

Summary: The study found that RFC1 disease is common across different populations, with CANVAS and ACC as highly diagnostic features, but the phenotype is variable and overlapping, spanning a spectrum of multisystem diseases. Treatment trials require a large number of patients to detect reduced progression.

NEUROLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice

Carlo Wilke et al.

EMBO MOLECULAR MEDICINE (2020)

添加到收藏夹

Review Neurosciences

Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders

Roger Kalla et al.

CURRENT NEUROPHARMACOLOGY (2019)

添加到收藏夹

Article Clinical Neurology

Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study

Carlo Wilke et al.

JOURNAL OF NEUROLOGY (2018)

添加到收藏夹

Article Neurosciences

Evaluation of multimodal segmentation based on 3D T1-, T2-and FLAIR-weighted images - the difficulty of choosing

Tobias Lindig et al.

NEUROIMAGE (2018)

添加到收藏夹

Article Clinical Neurology

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Theresa A. Zesiewicz et al.

NEUROLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia

Ilaria Giordano et al.

NEUROLOGY (2017)

添加到收藏夹

Article Neurosciences

Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus

Katharina Feil et al.

CEREBELLUM (2016)

添加到收藏夹

Article Multidisciplinary Sciences

4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6

Sriram Jayabal et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Fitting Linear Mixed-Effects Models Using lme4

Douglas Bates et al.

JOURNAL OF STATISTICAL SOFTWARE (2015)

添加到收藏夹

Article Clinical Neurology

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study

Heike Jacobi et al.

LANCET NEUROLOGY (2015)

添加到收藏夹

Article Neurosciences

Inventory of Non-Ataxia Signs (INAS): Validation of a New Clinical Assessment Instrument

H. Jacobi et al.

CEREBELLUM (2013)

添加到收藏夹

Editorial Material Medicine, General & Internal

被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Letter Clinical Neurology

Experience in a short-term trial with 4-Aminopyridine in cerebellar ataxia

I. Giordano et al.

JOURNAL OF NEUROLOGY (2013)

添加到收藏夹

Article Clinical Neurology

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

Manuela Neumann et al.

ACTA NEUROPATHOLOGICA (2009)

添加到收藏夹

Article Neurosciences

FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels

Fernanda Laezza et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2009)

添加到收藏夹

Article Neurosciences

FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons

Vikram G. Shakkottai et al.

NEUROBIOLOGY OF DISEASE (2009)

添加到收藏夹

Article Clinical Neurology

Second consensus statement on the diagnosis of multiple system atrophy

S. Gilman et al.

NEUROLOGY (2008)

添加到收藏夹

Article Clinical Neurology

Scale for the assessment and rating of ataxia -: Development of a new clinical scale

T. Schmitz-Huebsch et al.

NEUROLOGY (2006)

添加到收藏夹

Article Neurosciences

Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels

JY Lou et al.

JOURNAL OF PHYSIOLOGY-LONDON (2005)

添加到收藏夹

Article Clinical Neurology

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale

SH Subramony et al.

NEUROLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.